Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.59M Buy
+304,226
New +$6.5M 0.32% 65
2024
Q4
Sell
-276,009
Closed -$6.23M 62
2024
Q3
$6.23M Buy
276,009
+97,680
+55% +$2.23M 0.88% 31
2024
Q2
$4.41M Buy
+178,329
New +$5.06M 0.6% 40

Other funds holding ADNT

Covalis Capital's ADNT Position: Q2 2026 in Review

Covalis Capital opened a new position in Adient (ADNT) in Q2 2026: 304,226 shares worth $5.59M. The stake represents 0.32% of the portfolio and ranks #65 among its holdings. This is a return to the name: Covalis Capital previously reported a position in ADNT as recently as Q3 2024.

Covalis Capital first reported a position in ADNT in Q2 2024 and has held it in 3 quarters since. The position peaked at $6.23M in Q3 2024. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Covalis Capital held 304,226 shares of Adient worth $5.59M as of Q2 2026.
  • Adient was a new Covalis Capital position in Q2 2026.
  • Adient made up 0.32% of Covalis Capital's portfolio in Q2 2026, its #65 holding.
  • Covalis Capital first reported a position in Adient in Q2 2024 and has held it in 3 quarters since.
  • Covalis Capital's Adient position peaked at $6.23M in Q3 2024.
  • 313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Covalis Capital's 13F filing for Q2 2026, filed 13 Aug 2026.